Evidence mapPaperPMID 40101329Full record

ArticleEndocrinology and metabolism (Seoul, Korea)2025

Antilipolytic Insulin Sensitivity Indices Measured during an Oral Glucose Challenge: Associations with Insulin-Glucose Clamp and Central Adiposity in Women without Diabetes.

Foued Naimi, Christophe Richer Dit Laflèche, Marie-Claude Battista, André C Carpentier, Jean-Patrice Baillargeon

Abstract read
In one paragraph

Article in Endocrinology and metabolism (Seoul, Korea), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Foued NaimiDivision of Endocrinology, Department of Medicine, University of Sherbrooke (Université de Sherbrooke), Sherbrooke, QC, Canada.
Christophe Richer Dit LaflècheDivision of Endocrinology, Department of Medicine, University of Sherbrooke (Université de Sherbrooke), Sherbrooke, QC, Canada.
Marie-Claude BattistaDivision of Endocrinology, Department of Medicine, University of Sherbrooke (Université de Sherbrooke), Sherbrooke, QC, Canada.
André C CarpentierDivision of Endocrinology, Department of Medicine, University of Sherbrooke (Université de Sherbrooke), Sherbrooke, QC, Canada.
Jean-Patrice BaillargeonDivision of Endocrinology, Department of Medicine, University of Sherbrooke (Université de Sherbrooke), Sherbrooke, QC, Canada.

Funding

CIHR MOP-97965
6 · The paper itself

Abstract

backgruoundTissue overexposure to non-esterified fatty acids (NEFA) contributes to the development of metabolic conditions, with insulin-mediated suppression of lipolysis being an important mechanism in limiting this overexposure. We investigated which dynamic NEFA insulin-suppression indices derived from the oral glucose tolerance test (OGTT) were best associated with those derived from the insulin-glucose clamp, as well as with central adiposity and glucoregulatory parameters.

methodsThis cross-sectional study recruited 29 women without diabetes, 15 healthy women, and 14 women with polycystic ovary syndrome. The OGTT indices of NEFA insulin-suppression were the decremental NEFA area under the curve, negative log-linear NEFA slope, percentage of NEFA suppression (%NEFAsupp) and time to suppress NEFA levels by 50% (T50NEFA). The indices derived from the two-step euglycemic-hyperinsulinemic clamp (low-dose insulin step) were delta NEFA and %NEFAsupp.

resultsAmong the OGTT and clamp indices, T50NEFA[OGTT] and %NEFAsupp[clamp] showed the closest associations in both subgroups (r=-0.58). Additionally, T50NEFA correlated significantly in all women with waist circumference (r=0.64), body fat percentage (r=0.60), fasting insulinemia (r=0.53), and M-value insulin sensitivity index (r=-0.45). Similarly, %NEFAsupp[clamp] correlated significantly in all women with waist circumference (r=-0.57), body fat percentage (r=-0.54), fasting insulinemia (r=-0.55), and M-value insulin sensitivity index (r=0.51). T50NEFA and %NEFAsupp[clamp] also correlated with other anthropometric and metabolic parameters associated with lipotoxicity.

conclusionFor dynamic testing of NEFA insulin-suppression in women, T50NEFA was the OGTT-derived index best correlated with a clamp index (%NEFAsupp). These indices were also the most closely associated with anthropometric and glucoregulatory parameters. Thus, the OGTT-derived T50NEFA appears valid for assessing dynamic antilipolytic insulin action.

Indexed as

AdiposityInsulinInsulin ResistanceLipolysisObesity, AbdominalPolycystic Ovary SyndromeAdultBlood GlucoseCross-Sectional StudiesFatty Acids, NonesterifiedFemaleGlucose Clamp TechniqueGlucose Tolerance TestHumansMiddle AgedYoung AdultBlood GlucoseFatty Acids, NonesterifiedInsulinAdipose tissueEndocrinology and metabolismFatty acids, nonesterifiedInsulin resistanceLipolysisLipotoxicity

Identifiers

PMID40101329
PMCPMC12409164

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.